EUVIMEDEUVIMED entdecken
Crossref

Immunogenicity of an in-silico designed multi-epitope DNA vaccine encoding ROP21 and ROP29 of Toxoplasma gondii against both acute and chronic toxoplasmosis in BALB/c mice

Amir Karimipour-Saryazdi, Fatemeh Ghaffarifar, Abdolhossein Dalimi, Masoud Foroutan, Javid Sadraei, John Horton

Microbial Pathogenesis · 2025

DOI: 10.1016/j.micpath.2025.107321 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Microbial Pathogenesis, 2025. Verfasst von Amir Karimipour-Saryazdi und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Parasitology, Faculty of Medical Sciences, Tarbiat Modares University, Tehran, Iran. Electronic address: amirkarimipour@modares.ac.ir. Hauptthemen laut MEDLINE: Toxoplasma, Vaccines, DNA, Protozoan Vaccines, Protozoan Proteins. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 57 Literaturangaben. Gefördert von: Faculty of Medical Sciences, Tarbiat Modares University, Tarbiat Modares University, Iran National Science Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Toxoplasma infections are highly prevalent worldwide and can cause serious complications in immunocompromised individuals and lead to congenital infections in neonates. Despite ongoing efforts to develop T. gondii vaccines, none have been developed. A potential target, the ROP21 protein catalyzes the phosphorylation of additional protein substrates and ROP29 is critical for chronic Toxoplasma gondii infection. In this study, recombinant plasmid with epitopes of ROP21 and ROP29 were used as DNA vaccine. METHODS: An immunoinformatics approach was employed to design a multi-epitope DNA vaccine encoding T. gondii ROP21 and ROP29. The bioinformatic outputs supported the immunogenic and non-allergic nature of multi-epitope vaccine. The recombinant plasmid was transfected in HEK cells. Thereafter, the protective effect of the DNA vaccine was evaluated in BALB/c mice by way of vaccination and challenge of these mice with acute RH and chronic PRU strains of T. gondii, respectively. The immunological responses of the control and vaccinated groups were assessed using survival time, lymphocyte proliferation assays, cytokine and antibody measurements, and determination of the parasite load in the spleen with real-time PCR. FINDINGS: Multiple epitope (ROP21 and ROP29) DNA immunization stimulated cellular and humoral immune reactions in BALB/c mice and lengthened their life following challenge. Multiple epitope proteins increased significantly the total IgG antibody concentrations, triggered increased IFN-γ cytokine production, increased the mixed IgG1/IgG2a response with a predominance of IgG2a, prolonged the survival duration and reduced the number of brain cysts. The in vivo findings indicated that the multi-epitope DNA vaccine elicited significant production of IgG antibodies (122.16 ng/ml) as well as IFN-γ (12.37 pg/ml) (p 0.05). CONCLUSIONS: We found that multiepitope protein vaccination could provide more protective immunity against chronic and acute toxoplasmosis infection compared to control.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ToxoplasmaVaccines, DNAProtozoan VaccinesProtozoan ProteinsToxoplasmosis, AnimalEpitopesToxoplasmosisImmunogenicity, VaccineAnimalsMice, Inbred BALB CMiceAntibodies, ProtozoanHumansCytokinesFemaleAntigens, ProtozoanDisease Models, AnimalHEK293 CellsParasite LoadChronic DiseaseSpleenComputer Simulation

Stichwörter der Autor:innen

AcuteChronicROP21ROP29Toxoplasma, DNAVaccine

Substanzen

Vaccines, DNAProtozoan VaccinesAntibodies, ProtozoanProtozoan ProteinsEpitopesCytokinesAntigens, Protozoan

Autor:innen und Institutionen

  • Department of Parasitology, Faculty of Medical Sciences, Tarbiat Modares University, Tehran, Iran. Electronic address: amirkarimipour@modares.ac.ir.
  • Department of Parasitology, Faculty of Medical Sciences, Tarbiat Modares University, Tehran, Iran. Electronic address: ghafarif@modares.ac.ir.
  • Department of Parasitology, Faculty of Medical Sciences, Tarbiat Modares University, Tehran, Iran. Electronic address: dalimi_a@modares.ac.ir.
  • Department of Basic Medical Sciences, Faculty of Medicine, Abadan University of Medical Sciences, Abadan, Iran. Electronic address: Masoud_foroutan_rad@yahoo.com.
  • Department of Parasitology, Faculty of Medical Sciences, Tarbiat Modares University, Tehran, Iran. Electronic address: sadraeij@modares.ac.ir.
  • Tropical Projects, Hitchin, United Kingdom. Electronic address: hedgepigs@aol.com.

Förderung

  • Faculty of Medical Sciences, Tarbiat Modares University
  • Tarbiat Modares University
  • Iran National Science Foundation

Zitieren

APA

Karimipour-Saryazdi, A., Ghaffarifar, F., Dalimi, A., Foroutan, M., Sadraei, J., & Horton, J. (2025). Immunogenicity of an in-silico designed multi-epitope DNA vaccine encoding ROP21 and ROP29 of Toxoplasma gondii against both acute and chronic toxoplasmosis in BALB/c mice. Microbial Pathogenesis. https://doi.org/10.1016/j.micpath.2025.107321

Vancouver

Karimipour-Saryazdi A, Ghaffarifar F, Dalimi A, Foroutan M, Sadraei J, Horton J. Immunogenicity of an in-silico designed multi-epitope DNA vaccine encoding ROP21 and ROP29 of Toxoplasma gondii against both acute and chronic toxoplasmosis in BALB/c mice. Microbial Pathogenesis. 2025. doi:10.1016/j.micpath.2025.107321

BibTeX
@article{KarimipourSaryazdi2025,
  author = {Karimipour-Saryazdi, Amir and Ghaffarifar, Fatemeh and Dalimi, Abdolhossein and Foroutan, Masoud and Sadraei, Javid and Horton, John},
  title = {Immunogenicity of an in-silico designed multi-epitope DNA vaccine encoding ROP21 and ROP29 of Toxoplasma gondii against both acute and chronic toxoplasmosis in BALB/c mice},
  journal = {Microbial Pathogenesis},
  year = {2025},
  doi = {10.1016/j.micpath.2025.107321}
}
Kostenlos starten →